Skip to content

Study of clinical course and prognosis of severe asthma in Korea by long-term follow-up

Long-term follow-up registry study for patients with severe asthma in Korea

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007960
Enrollment
500
Registered
2022-12-05
Start date
2022-11-21
Completion date
Unknown
Last updated
2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult asthma patients over the age of 19 Patients who have been treated for more than 1 year after being diagnosed with asthma by a specialist Severe asthma per the 2014 ATS/ERS guidelines at the time of enrollment; - Asthma that is not continuously controlled despite GINA step 4-5 drug treatment - Asthma that is not controlled when ICS/OCS is reduced even though it is controlled with GINA step 4-5 drug treatment

Exclusion criteria

Exclusion criteria: Severe respiratory diseases other than asthma, such as tuberculosis destructive lung disease and interstitial lung disease Severe mental illness that can impede research, such as schizophrenia Severe systemic disease (chronic renal failure requiring dialysis, severe liver disease, heart disease) When continuous oral steroid administration is required for other diseases

Design outcomes

Primary

MeasureTime frame
exacerbation (OCS use more than 3 days, ED visit, hospitalization)

Secondary

MeasureTime frame
asthma control

Countries

Korea, Republic of

Contacts

Public ContactSang-Heon Kim

Hanyang University Seoul Hospital

sangheonkim@hanyang.ac.kr+82-2-2290-8336

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026